{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:24:56Z","timestamp":1777983896194,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Daiwa Pharmaceutical Co., Ltd.","award":["Private Treaty"],"award-info":[{"award-number":["Private Treaty"]}]},{"name":"BioMedica Nutraceuticals Pty Ltd.","award":["Private Treaty"],"award-info":[{"award-number":["Private Treaty"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41554-8","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:15:21Z","timestamp":1772460921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of rice bran arabinoxylan compound on quality of life of cancer patients during active treatment: a randomised placebo-controlled pilot trial"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0534-3673","authenticated-orcid":false,"given":"Soo Liang","family":"Ooi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-3878","authenticated-orcid":false,"given":"Peter S.","family":"Micalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-8523","authenticated-orcid":false,"given":"Robert","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-406X","authenticated-orcid":false,"given":"Judith","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-203X","authenticated-orcid":false,"given":"Suzanne","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-7397","authenticated-orcid":false,"given":"Steven","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5369-1013","authenticated-orcid":false,"given":"Terry","family":"Golombick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-5781","authenticated-orcid":false,"given":"Sok Cheon","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"41554_CR1","unstructured":"Ferlay, J. et al. Global Cancer Observatory: Cancer Today (International Agency for Research on Cancer, Lyon, France, 2024). https:\/\/gco.iarc.who.int\/today"},{"issue":"3","key":"41554_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 74(3), 229\u2013263 (2024).","journal-title":"CA: A Cancer J. Clin."},{"issue":"2","key":"41554_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0039-6109(05)70196-1","volume":"80","author":"M Tamburini","year":"2000","unstructured":"Tamburini, M., Casali, P. G. and Miccinesi, G. Outcome assessment in cancer management. Surg. Clin. N. Am. 80(2), 471\u2013486 (2000).","journal-title":"Surg. Clin. N. Am."},{"key":"41554_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fphar.2013.00057","volume":"4","author":"MO Palumbo","year":"2013","unstructured":"Palumbo, M. O. et al. Systemic cancer therapy: achievements and challenges that lie ahead. Front. Pharmacol. 4, 57 (2013).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"41554_CR5","first-page":"e38301","volume":"15","author":"B Katta","year":"2023","unstructured":"Katta, B., Vijayakumar, C., Dutta, S., Dubashi, B. and Nelamangala Ramakrishnaiah, V. P. The incidence and severity of patient-reported side effects of chemotherapy in routine clinical care: A prospective observational study. Cureus 15(4), e38301 (2023).","journal-title":"Cureus"},{"issue":"4","key":"41554_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11764-020-00869-9","volume":"14","author":"J Firkins","year":"2020","unstructured":"Firkins, J., Hansen, L., Driessnack, M. and Dieckmann, N. Quality of life in chronic cancer survivors: A meta-analysis. J. Cancer Surviv. 14(4), 504\u2013517 (2020).","journal-title":"J. Cancer Surviv."},{"issue":"3","key":"41554_CR7","first-page":"217","volume":"12","author":"S Jitender","year":"2018","unstructured":"Jitender, S., Mahajan, R., Rathore, V. and Choudhary, R. Quality of life of cancer patients. J. Exp. Ther. Oncol. 12(3), 217\u2013221 (2018).","journal-title":"J. Exp. Ther. Oncol."},{"issue":"1","key":"41554_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12955-023-02189-9","volume":"21","author":"LB Nguyen","year":"2023","unstructured":"Nguyen, L. B. et al. Impact of interventions on the quality of life of cancer patients: A systematic review and meta-analysis of longitudinal research. Health Qual. Life Outcomes 21(1), 112 (2023).","journal-title":"Health Qual. Life Outcomes"},{"issue":"2","key":"41554_CR9","first-page":"110","volume":"9","author":"JI Nolazco","year":"2023","unstructured":"Nolazco, J. I. and Chang, S. L. The role of health-related quality of life in improving cancer outcomes. J. Clin. Translational Res. 9(2), 110\u2013114 (2023).","journal-title":"J. Clin. Translational Res."},{"issue":"8","key":"41554_CR10","first-page":"3467","volume":"28","author":"I Olver","year":"2020","unstructured":"Olver, I. et al. Supportive care in cancer\u2014a MASCC perspective. Support. Care Cancer 28(8), 3467\u20133475 (2020).","journal-title":"Support. Care Cancer"},{"issue":"1","key":"41554_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/13880209.2024.2349042","volume":"62","author":"SL Ooi","year":"2024","unstructured":"Ooi, S. L., Micalos, P. S., Kim, J. and Pak, S. C. Rice bran arabinoxylan compound as a natural product for cancer treatment\u2014an evidence-based assessment of the effects and mechanisms. Pharm. Biol. 62(1), 367\u2013393 (2024).","journal-title":"Pharm. Biol."},{"issue":"2","key":"41554_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1534735417735379","volume":"17","author":"SL Ooi","year":"2018","unstructured":"Ooi, S. L., McMullen, D., Golombick, T. and Pak, S. C. Evidence-based review of BioBran\/MGN-3 arabinoxylan compound as a complementary therapy for conventional cancer treatment. Integr. Cancer Ther. 17(2), 165\u2013178 (2018).","journal-title":"Integr. Cancer Ther."},{"key":"41554_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-981-19-5735-2_8","volume-title":"Modified rice bran arabinoxylan: Therapeutic applications in cancer and other diseases","author":"SL Ooi","year":"2023","unstructured":"Ooi, S. L., Pak, S. C. and Micalos, P. S. Health-related quality of life. In  Modified rice bran arabinoxylan: Therapeutic applications in cancer and other diseases, (eds Pak, S. C., Ooi, S. L., Micalos, P. S. and Ghoneum, M. H.) 87\u201399. (Springer, Singapore, 2023)."},{"key":"41554_CR14","doi-asserted-by":"publisher","first-page":"100580","DOI":"10.1016\/j.conctc.2020.100580","volume":"19","author":"SL Ooi","year":"2020","unstructured":"Ooi, S. L. et al. Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial. Contemp. Clin. Trials Commun. 19, 100580 (2020).","journal-title":"Contemp. Clin. Trials Commun."},{"issue":"1","key":"41554_CR15","first-page":"e53188","volume":"16","author":"SL Ooi","year":"2024","unstructured":"Ooi, S. L., Micalos, P. S., Zielinski, R. and Pak, S. C. Rice bran arabinoxylan compound and quality of life (RBAC-QoL) of cancer patients: An interim analysis of the RBAC-QoL Study. Cureus 16(1), e53188 (2024).","journal-title":"Cureus"},{"key":"41554_CR16","unstructured":"The National Clinical Trials Governance Framework and User Guide for Health Service Organisations Conducting Clinical Trials (Australia Government Department of Health, The National Clinical Trials Governance Framework and User Guide for Health Service Organisations Conducting Clinical Trials, 2022)."},{"issue":"1","key":"41554_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F., Altman, D. G. & Moher, D. The CG CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Med. 8(1), 18 (2010).","journal-title":"BMC Med."},{"key":"41554_CR18","unstructured":"Fayers, P. M. et al. EORTC QLQ-C30 Scoring Manual (European Organisation for Research and Treatment of Cancer, 2001)."},{"issue":"2","key":"41554_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/nu7020785","volume":"7","author":"CE Collins","year":"2015","unstructured":"Collins, C. E. et al. The comparative validity and reproducibility of a diet quality index for adults: The Australian Recommended Food Score. Nutrients 7(2), 785\u2013798 (2015).","journal-title":"Nutrients"},{"issue":"1","key":"41554_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1479-5868-8-115","volume":"8","author":"PH Lee","year":"2011","unstructured":"Lee, P. H., Macfarlane, D. J., Lam, T. H. and Stewart, S. M. Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review. Int. J. Behav. Nutr. Phys. Activity 8(1), 115 (2011).","journal-title":"Int. J. Behav. Nutr. Phys. Activity"},{"issue":"12","key":"41554_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v050.i12","volume":"50","author":"K Noguchi","year":"2012","unstructured":"Noguchi, K., Gel, Y. R., Brunner, E. & Konietschke, F. nparLD: An R software package for the nonparametric analysis of longitudinal data in factorial experiments. J. Stat. Softw. 50(12), 1\u201323 (2012).","journal-title":"J. Stat. Softw."},{"issue":"3","key":"41554_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1590\/2176-9451.20.3.013-015.ebo","volume":"20","author":"SG Falci","year":"2015","unstructured":"Falci, S. G. and Marques, L. S. CONSORT: When and how to use it. Dent. Press. J. Orthod. 20(3), 13\u201315 (2015).","journal-title":"Dent. Press. J. Orthod."},{"issue":"1","key":"41554_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks, K. et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J. Clin. Oncol. 29(1), 89\u201396 (2011).","journal-title":"J. Clin. Oncol."},{"key":"41554_CR24","unstructured":"Tan, D. F. S. & Flores, J. A. S. The immunomodulating effects of arabinoxylan rice bran (Lentin) on hematologic profile, nutritional status and quality of life among head and neck carcinoma patients undergoing radiation therapy: A double blind randomized control trial. Radiol. J. 12, 11 (2020)."},{"issue":"4","key":"41554_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1037\/1082-989X.8.4.434","volume":"8","author":"S Olejnik","year":"2003","unstructured":"Olejnik, S. and Algina, J. Generalized eta and omega squared statistics: measures of effect size for some common research designs. Psychol. Methods 8(4), 434\u2013447 (2003).","journal-title":"Psychol. Methods"},{"issue":"12","key":"41554_CR26","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1093\/annonc\/mdy447","volume":"29","author":"C Wayant","year":"2018","unstructured":"Wayant, C. and Vassar, M. A comparison of matched interim analysis publications and final analysis publications in oncology clinical trials. Ann. Oncol. 29(12), 2384\u20132390 (2018).","journal-title":"Ann. Oncol."},{"key":"41554_CR27","doi-asserted-by":"crossref","unstructured":"Masood, A. I., Sheikh, R., Anwer, R. A. and BIOBRAN MGN-3; effect of reducing side effects of chemotherapy in breast cancer patients. Prof. Med. J. [Internet] 20(1), 13\u2009 (2013).","DOI":"10.29309\/TPMJ\/2013.20.01.4869"},{"key":"41554_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.eujim.2016.10.004","volume":"8","author":"G Petrovics","year":"2016","unstructured":"Petrovics, G. et al. Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3 Arabinoxylane) and targeted radiofrequency heat therapy. Eur. J. Integr. Med. 8, 29\u201335 (2016).","journal-title":"Eur. J. Integr. Med."},{"issue":"1","key":"41554_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.annonc.2019.10.008","volume":"31","author":"DE Magee","year":"2020","unstructured":"Magee, D. E. et al. Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: A systematic review and meta-analysis of randomized clinical trials. Ann. Oncol. 31(1), 50\u201360 (2020).","journal-title":"Ann. Oncol."},{"key":"41554_CR30","doi-asserted-by":"publisher","first-page":"e8668","DOI":"10.1136\/bmj.e8668","volume":"346","author":"ML Bell","year":"2013","unstructured":"Bell, M. L., Kenward, M. G., Fairclough, D. L. and Horton, N. J. Differential dropout and bias in randomised controlled trials: when it matters and when it may not. BMJ 346, e8668 (2013).","journal-title":"BMJ"},{"issue":"1","key":"41554_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12874-021-01259-0","volume":"21","author":"P Gebert","year":"2021","unstructured":"Gebert, P., Schindel, D., Frick, J., Schenk, L. and Grittner, U. Characteristics and patient-reported outcomes associated with dropout in severely affected oncological patients: An exploratory study. BMC Med. Res. Methodol. 21(1), 77 (2021).","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"41554_CR32","first-page":"267","volume":"14","author":"K Takahara","year":"2004","unstructured":"Takahara, K. and Sano, K. The life prolongation and QOL improvement effect of rice bran arabinoxylan derivative (MGN-3, Biobran) for progressive cancer. Clin. Pharmacol. Therapy 14(3), 267\u2013271 (2004).","journal-title":"Clin. Pharmacol. Therapy"},{"issue":"1","key":"41554_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1475-2891-11-27","volume":"11","author":"CG Lis","year":"2012","unstructured":"Lis, C. G., Gupta, D., Lammersfeld, C. A., Markman, M. and Vashi, P. G. Role of nutritional status in predicting quality of life outcomes in cancer\u2014a systematic review of the epidemiological literature. Nutr. J. 11(1), 27 (2012).","journal-title":"Nutr. J."},{"key":"41554_CR34","doi-asserted-by":"crossref","unstructured":"Abbasi, B., Hayat, A., Lyons, M., Gupta, A. and Gupta, S. Serum protein and electrolyte imbalances are associated with chemotherapy induced neutropenia. Heliyon 8(7) (2022).","DOI":"10.1016\/j.heliyon.2022.e09949"},{"issue":"1","key":"41554_CR35","first-page":"38","volume":"14","author":"MZ Rahman","year":"2005","unstructured":"Rahman, M. Z. and Begum, B. A. Serum total protein, albumin and A\/G ratio in different grades of protein energy malnutrition. Mymensingh Med. J. 14(1), 38\u201340 (2005).","journal-title":"Mymensingh Med. J."},{"key":"41554_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fimmu.2020.00249","volume":"11","author":"L Lanser","year":"2020","unstructured":"Lanser, L. et al. Inflammation-induced tryptophan breakdown is related with anemia, fatigue, and depression in cancer. Front. Immunol. 11, 249 (2020).","journal-title":"Front. Immunol."},{"issue":"1","key":"41554_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic, D., Song, M., Wang, L. and Zhang, Y. Roles of IFN-\u03b3 in tumor progression and regression: A review. Biomark. Res. 8(1), 49 (2020).","journal-title":"Biomark. Res."},{"issue":"2","key":"41554_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/01635580701627285","volume":"60","author":"NK Badr El-din","year":"2008","unstructured":"Badr El-din, N. K., Noaman, E. and Ghoneum, M. In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3\/Biobran on Ehrlich carcinoma-bearing mice. Nutr. Cancer 60(2), 235\u2013244 (2008).","journal-title":"Nutr. Cancer"},{"issue":"2","key":"41554_CR39","first-page":"89","volume":"14","author":"M Ghoneum","year":"1998","unstructured":"Ghoneum, M. Enhancement of human natural killer cell activity by modified arabinoxylane from rice bran (MGN-3). Int. J. ImmunotherAcademic 14(2), 89\u201399 (1998).","journal-title":"Int. J. Immunother."},{"issue":"12","key":"41554_CR40","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1211\/0022357044922","volume":"56","author":"M Ghoneum","year":"2004","unstructured":"Ghoneum, M. and Abedi, S. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3\/Biobran). J. Pharm. Pharmacol. 56(12), 1581\u20131588 (2004).","journal-title":"J. Pharm. Pharmacol."},{"key":"41554_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-19-5735-2_6","volume-title":"Modified Rice Bran Arabinoxylan: Therapeutic Applications in Cancer and Other Diseases","author":"T Hajto","year":"2023","unstructured":"Hajto, T. The therapeutic application of rbac in cancer. In: (eds Pak, S. C., Ooi, S. L., Micalos, P. S. and Ghoneum, M. H.) Modified Rice Bran Arabinoxylan: Therapeutic Applications in Cancer and Other Diseases. Singapore: Springer Nature Singapore; 67\u201379. (2023)."},{"issue":"8","key":"41554_CR42","doi-asserted-by":"publisher","first-page":"e20212434","DOI":"10.1084\/jem.20212434","volume":"219","author":"A Shemesh","year":"2022","unstructured":"Shemesh, A., Pickering, H., Roybal, K. T. and Lanier, L. L. Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion. J. Exp. Med. 219(8), e20212434 (2022).","journal-title":"J. Exp. Med."},{"issue":"3","key":"41554_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00262-012-1344-z","volume":"62","author":"D Cholujova","year":"2013","unstructured":"Cholujova, D. et al. MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer Immunol. Immunother 62(3), 437\u2013445 (2013).","journal-title":"Cancer Immunol. Immunother"},{"issue":"9","key":"41554_CR44","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1002\/cam4.1700","volume":"7","author":"L Ni","year":"2018","unstructured":"Ni, L. and Lu, J. Interferon gamma in cancer immunotherapy. Cancer Med. 7(9), 4509\u20134516 (2018).","journal-title":"Cancer Med."},{"key":"41554_CR45","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","volume":"10","author":"A Viola","year":"2019","unstructured":"Viola, A., Munari, F., S\u00e1nchez-Rodr\u00edguez, R., Scolaro, T. and Castegna, A. The metabolic signature of macrophage responses. Frontier Immunol. 10, 1462 (2019).","journal-title":"Frontier Immunol."},{"key":"41554_CR46","doi-asserted-by":"crossref","unstructured":"Singh, M. Chapter 3 - Interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer. In  Multifaceted Role of IL-1 in Cancer and Inflammation (ed Singh, M.) 87\u201398 (Academic, 2023).","DOI":"10.1016\/B978-0-12-824273-5.00007-6"},{"issue":"6","key":"41554_CR47","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/0192-0561(92)90142-8","volume":"14","author":"P Conti","year":"1992","unstructured":"Conti, P. et al. Human recombinant interleukin-1 receptor antagonist (hrIL-1ra) enhances the stimulatory effect of interleukin-2 on natural killer cell activity against molt-4 target cells. Int. J. Immunopharmacol. 14(6), 987\u2013993 (1992).","journal-title":"Int. J. Immunopharmacol."},{"key":"41554_CR48","doi-asserted-by":"publisher","first-page":"122276","DOI":"10.1016\/j.lfs.2023.122276","volume":"335","author":"Z Fang","year":"2023","unstructured":"Fang, Z., Jiang, J. and Zheng, X. Interleukin-1 receptor antagonist: An alternative therapy for cancer treatment. Life Sci. 335, 122276 (2023).","journal-title":"Life Sci."},{"issue":"12","key":"41554_CR49","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/apm.12288","volume":"122","author":"N Stanilov","year":"2014","unstructured":"Stanilov, N., Miteva, L., Jovchev, J., Cirovski, G. and Stanilova, S. The prognostic value of preoperative serum levels of IL-12p40 and IL-23 for survival of patients with colorectal cancer. APMIS 122(12), 1223\u20131229 (2014).","journal-title":"APMIS"},{"issue":"9","key":"41554_CR50","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3390\/molecules26092539","volume":"26","author":"SL Ooi","year":"2021","unstructured":"Ooi, S. L. et al. The health-promoting properties and clinical applications of rice bran arabinoxylan modified with shiitake mushroom enzyme\u2014a narrative review. Molecules 26(9), 2539 (2021).","journal-title":"Molecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41554-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41554-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41554-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:02:47Z","timestamp":1775559767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41554-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41554"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41554-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5837950\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Ethics Committee (HREC) of Concord Repatriation General Hospital, Sydney Local Health District (Application No. 2019\/ ETH00489) and Charles Sturt University HREC (Protocol No. H19244). All participants in the study provided written informed consent before starting the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript has been read and approved by all named authors, and there are no other persons who satisfied the criteria for authorship but are not listed. All authors had agreed to the publication. The manuscript contains no participant\u2019s personal data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11584"}}